Astrana Health 旗下八個 ACO 於 2024 年創造 1.204 億美元共享儲蓄

EX-99.1
2
tm2620233d1_ex99-1.htm
EXHIBIT 99.1

 

 

Exhibit 99.1

 

 

 

Astrana Health ACOs Deliver $120.4
Million in Gross Shared Savings in 2024 Performance Year

 

All Eight
ACOs Achieve Net Shared Savings

 

ALHAMBRA, Calif.,
July 13, 2026/PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities,
the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible,
high-quality, and high-value care to all, today announced that its Accountable Care Organizations (ACOs) generated $120.4 million in
gross shared savings during the 2024 performance year.

 

All eight of
Astrana's affiliated ACOs generated shared savings, including five participating in the Medicare Shared Savings Program (MSSP) and three
participating in the ACO Realizing Equity, Access and Community Health (ACO REACH) model, demonstrating the strength and consistency of
Astrana’s physician-led value-based care platform and its commitment to improving outcomes for patients and providers across the
nation.

 

“Generating
shared savings across all eight of our affiliated ACOs is a powerful validation of our physician-centric model and the strength of the
infrastructure we provide to our partners,” said Brandon Sim, President and CEO of Astrana Health. “Our integrated platform
brings together AI-enabled technology, care management, analytics, and operational infrastructure to enable providers to succeed in value-based
care at scale. As more physicians transition to value-based care, we believe our platform is uniquely positioned to help them succeed
while delivering better outcomes at a lower total cost of care.”

 

  

  

 

 

2024 Performance
Year Highlights

 

·$120.4
 million in gross shared savings

   

 

·100%
 of Astrana’s eight affiliated ACOs generated shared savings

   

 

·Nearly
 100,000 Medicare beneficiaries served across Astrana’s eight affiliated ACOs

   

 

·Astrana
 Care Partners ACO (A5450) ranked seventh among 476 MSSP ACOs nationwide in net shared savings
 per beneficiary in its first performance year

 

These results further validate Astrana’s
broader physician enablement platform, which supports providers across Medicare, Medicaid, Commercial, and ACA populations.

 

Today,
Astrana supports more than 20,000 providers
caring for approximately 1.55 million patients through partnerships with more than 20 payers nationwide. In fiscal year 2025, the Company
generated $3.18 billion in revenue and $205.4 million in adjusted EBITDA(1), underscoring the
scale and durability of its physician-centric, technology-enabled operating model. Astrana continues to expand its AI-enabled
platform in 2026, growing revenue 56% year over year in the first quarter while
empowering more providers to succeed in value-based care.

 

Astrana's 2024
performance contributes to the broader momentum in Medicare's accountable care programs, which continue to demonstrate their effectiveness
in improving care coordination, reducing unnecessary hospitalizations, and generating substantial savings for taxpayers while improving
the patient experience. Astrana remains focused on expanding its physician enablement platform to help more providers deliver coordinated,
high-quality care across the communities they serve.

 

(1)
See “Reconciliation of Net Income to EBITDA and Adjusted EBITDA” and “Use of Non-GAAP Financial Measures” below
for additional information.

 

  

  

 

 

About Astrana
Health

 

Astrana Health
is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's
perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks
to enable proactive, preventive care at scale – improving patient outcomes, enhancing patient experiences, supporting provider
well-being, and driving greater value across the healthcare system.

 

Today, Astrana
supports more than 20,000 providers and approximately 1.55 million patients in value-based care arrangements through its affiliated provider
networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together,
Astrana is building the healthcare system we all deserve – one that delivers better care, better experiences, and better outcomes
for all.

 

For more information about Astrana Health's
ACO performance and value-based care initiatives, visit https://www.astranahealth.com/

 

Forward-Looking
Statements:

 

This press
release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements
about the performance of the Company’s ACOs, the Company’s continued growth and expansion, including of the ACO operations,
the Company's ability to meet operational goals, ability to meet expectations in deployment of care coordination and management capabilities,
ability to decrease cost of care while improving quality and outcomes, ability to deliver sustainable revenue and EBITDA growth as well
as long-term value, ability to respond to the changing environment, and statements about the Company's liquidity and successful completion
and implementation of strategic growth plans. Forward-looking statements reflect current views with respect to future events and financial
performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the
Company’s management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual
results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known
and unknown, including the risk factors described from time to time in the Company's reports to the Securities and Exchange Commission,
including, without limitation the risk factors discussed in the Company’s Annual Report on Form 10-K for the year ended December
31, 2025, and subsequent quarterly reports on Form 10-Q. Any forward-looking statements made by the Company in this release speaks only
as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as
a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

 

  

  

 

 

FOR MORE
INFORMATION, PLEASE CONTACT:

 

To learn about ACO participation, contact
Sean Zagari, [email protected]

 

Investor Relations
[email protected]

 

Reconciliation
of Net Income to EBITDA and Adjusted EBITDA 

 

 
   
 Year Ended  December 31, 

 
 (in thousands) 
 2025 

 
 Net income 
 $24,076 

 
 Interest expense 
  49,928 

 
 Interest income 
  (12,157)

 
 Provision for income taxes 
  15,530 

 
  Depreciation and amortization 
  45,749 

 
 EBITDA 
  123,126 

 
   
    

 
 Income from equity method investments 
  (1,708)

 
 Other, net 
  45,405(1)

 
 Stock-based compensation 
  38,601 

 
 Adjusted EBITDA 
 $205,424 

 

 

(1)
Other, net, for the year ended December 31, 2025, relates to $13.0 million for one-time legal matter costs, $25.9 million for one-time
transaction-related costs, debt issuance costs incurred in connection with our Second Amended and Restated Credit Facility, certain costs
and final settlement for some of our acquisitions, and severance fees incurred, partially offset by employer retention tax credits
related to COVID-19 relief. 

 

  

  

 

 

Use of Non-GAAP
Financial Measures

 

This press
release contains the non-GAAP financial measures EBITDA and Adjusted EBITDA, of which the most directly comparable financial measure
presented in accordance with U.S. generally accepted accounting principles ("GAAP") is net income. These measures are not in
accordance with, or alternatives to, GAAP, and may be calculated differently from similar non-GAAP financial measures used by other companies.
We use Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-making, and as
a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before
interest expense, interest income, income taxes, depreciation, and amortization, excluding income or loss from equity method investments,
non-recurring and non-cash transactions, and stock-based compensation.

 

We believe
the presentation of these non-GAAP financial measures provides investors with relevant and useful information, as it allows investors
to evaluate the operating performance of the business activities without having to account for differences recognized because of non-core
or non-recurring financial information. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors
are provided with a more meaningful understanding of our ongoing operating performance. In addition, these non-GAAP financial measures
are among those indicators we use as a basis for evaluating operational performance, allocating resources, and planning and forecasting
future periods. Non-GAAP financial measures are not intended to be considered in isolation, or as a substitute for, GAAP financial measures.
Other companies may calculate EBITDA and Adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes.
To the extent this press release contains historical or future non-GAAP financial measures, we have provided corresponding GAAP financial
measures for comparative purposes. The reconciliation between certain GAAP and non-GAAP measures are provided above.